Advanced Biomed Inc. Common Stock (ADVB) — Cash Flow-to-Debt Ratio
Advanced Biomed Inc. Common Stock (ADVB) has a Cash Flow-to-Debt Ratio of -0.01x as of December 2025, meaning its operating cash flow of $-15.81K could theoretically repay 0% of its total liabilities ($1.37 Million) in one year. See Advanced Biomed Inc. Common Stock free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Advanced Biomed Inc. Common Stock Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Advanced Biomed Inc. Common Stock across 5 annual periods. Also explore Advanced Biomed Inc. Common Stock equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Advanced Biomed Inc. Common Stock (2021–2025)
Year-by-year debt coverage analysis for Advanced Biomed Inc. Common Stock. For market capitalisation and broader financial context, see ADVB market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $-181.46K | $3.03 Billion | ▲ +100.0% |
| 2024 | -0.76x | $-2.13 Million | $2.80 Million | ▲ +15.5% |
| 2023 | -0.90x | $-2.96 Million | $3.29 Million | ▼ -290.9% |
| 2022 | -0.23x | $-741.45K | $3.22 Million | ▲ +98.5% |
| 2021 | -15.73x | $-473.98K | $30.13K | — |